Advisory Services Network’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
Other funds holding ACXP
VCM
VFT
PFS
WIM
Advisory Services Network's ACXP Position: Q1 2026 in Review
Advisory Services Network opened a new position in Acurx Pharmaceuticals (ACXP) in Q1 2026: 59 shares worth $219. The stake represents ﹤0.01% of the portfolio and ranks #4549 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in ACXP as recently as Q3 2025.
Advisory Services Network first reported a position in ACXP in Q4 2023 and has held it in 3 quarters since. The position peaked at $4.53K in Q4 2023. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.
- Advisory Services Network held 59 shares of Acurx Pharmaceuticals worth $219 as of Q1 2026.
- Acurx Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
- Acurx Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4549 holding.
- Advisory Services Network first reported a position in Acurx Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
- Advisory Services Network's Acurx Pharmaceuticals position peaked at $4.53K in Q4 2023.
- 21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.